Chinese biotech company BioCytogen has recently completed a series D+ round of financing of RMB970 million yuan. This round of financing was led by CMB International, followed by SDIC Ventures, China Life Equity, Bencao Capital, Tongchuangweiye and Pax Capital. This financing will be mainly used to support the rapid implementation of the company’s cooperation with […] Chinese Biotech Firm BioCytogen Raises RMB970 Million comes from China Money Network: Primary Data for China's Primary Markets! All Rights Reserved.